Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus
Conclusions:
During glucose-lowering therapy in T2DM, HBGI and LBGI offer insights into hyperglycemia and trends toward hypoglycemia, respectively; ADRR may be the optimal GV measure responsive to hypo- and hyperglycemic treatment effects.
Source: Journal of Diabetes Science and Technology - Category: Endocrinology Authors: Kovatchev, B., Umpierrez, G., DiGenio, A., Zhou, R., Inzucchi, S. E. Tags: Original Articles Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Science | Study